Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice.
about
NF-κB, the first quarter-century: remarkable progress and outstanding questionsImmunoregulatory Effects Triggered by Lactic Acid Bacteria Exopolysaccharides: New Insights into Molecular Interactions with Host CellsToll-like receptors in inflammatory bowel diseases: a decade later.The transcriptional specificity of NF-κB dimers is coded within the κB DNA response elementsThe IκB family member Bcl-3 coordinates the pulmonary defense against Klebsiella pneumoniae infection.Roles of Bcl-3 in the pathogenesis of murine type 1 diabetesInduction of Bcl-3 by acute binge alcohol results in toll-like receptor 4/LPS tolerance.Phosphatidylinositol 3-kinase-γ signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice.Oxymatrine prevents NF-κB nuclear translocation and ameliorates acute intestinal inflammation.Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodyniaAP-1 activated by toll-like receptors regulates expression of IL-23 p19.Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.C-type lectin receptors in the control of T helper cell differentiation.Interleukin (IL)-10 attenuates lipopolysaccharide-induced IL-6 production via inhibition of IkappaB-zeta activity by Bcl-3.BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection.Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development.
P2860
Q26822516-8EF3642D-EB17-40EF-B269-C821B6DDA5E6Q28078715-F72462D3-B2BE-4EBA-85C6-6C2742C6EDABQ34134813-6CEA28D7-73AF-454F-A000-7C0D47D0A014Q34206952-B0BA4F53-7BC1-46E5-BC9A-EBE7409C7E0CQ35185666-DA982B2E-98CE-4764-806B-50AC4FAF25B1Q35757083-4B7D8393-38B6-4943-AC01-230D839527B0Q36188860-3B3284C6-C6D6-4F7E-822D-E90C9BE4973DQ36487316-8085F83C-333F-495D-8AB4-6525372E5405Q36750781-2C97997B-E71A-4EDE-A889-F140A471F876Q37345563-2F9EDEF6-A9BB-4410-BA40-F8411AD43057Q37433256-E11274FB-03F2-4C50-9DAC-218530D6A6C0Q37445402-18DA0FCD-DB62-43AE-ACB2-25BEC7E92D66Q38862647-443C00F1-035D-48BD-8DC8-B01BF441CA06Q39827403-600391F3-9AA8-429F-8F3C-6FF81DFBF8F0Q40273147-D1C7FC5B-99A8-4E5A-B959-E1406900D2D8Q41002001-637CFE5F-FBF9-41AF-BCA8-3ED61572D7CEQ42005971-DE73489F-03F8-4A1D-867B-270D851281D5Q42453025-DD853FB8-5E7A-465F-B19C-6D8C7392D9FEQ52589510-79A05C74-DCEA-4E52-99CC-E967A67EE329
P2860
Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@ast
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@en
type
label
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@ast
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@en
prefLabel
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@ast
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@en
P2093
P2860
P356
P1476
Impaired Bcl3 up-regulation le ...... expression in IL-10(-/-) mice.
@en
P2093
Christian Jobin
Marcus Mühlbauer
Paula M Chilton
Thomas C Mitchell
P2860
P304
14182-14189
P356
10.1074/JBC.M709029200
P407
P577
2008-03-28T00:00:00Z